Three week versus six week immobilisation for stable Weber B type ankle fractures : randomised, multicentre, non-inferiority clinical trial

Show full item record



Permalink

http://hdl.handle.net/10138/300018

Citation

Kortekangas , T , Haapasalo , H , Flinkkilä , T , Ohtonen , P , Nortunen , S , Laine , H-J , Järvinen , T L N & Pakarinen , H 2019 , ' Three week versus six week immobilisation for stable Weber B type ankle fractures : randomised, multicentre, non-inferiority clinical trial ' , BMJ : British Medical Journal , vol. 364 , 5432 . https://doi.org/10.1136/bmj.k5432

Title: Three week versus six week immobilisation for stable Weber B type ankle fractures : randomised, multicentre, non-inferiority clinical trial
Author: Kortekangas, Tero; Haapasalo, Heidi; Flinkkilä, Tapio; Ohtonen, Pasi; Nortunen, Simo; Laine, Heikki-Jussi; Järvinen, Teppo L. N.; Pakarinen, Harri
Contributor: University of Helsinki, FICEBO
Date: 2019-01-23
Language: eng
Number of pages: 11
Belongs to series: BMJ : British Medical Journal
ISSN: 1756-1833
URI: http://hdl.handle.net/10138/300018
Abstract: OBJECTIVE To determine whether treatment of isolated stable Weber B type ankle fractures with a cast or a simple orthotic device for three weeks produces non-inferior outcomes compared with conventional immobilisation in a cast for six weeks. DESIGN Randomised, pragmatic, non-inferiority, clinical trial with blinded outcome assessment. SETTING Two major trauma centres in Finland, 22 December 2012 to 6 June 2016. PARTICIPANTS 247 skeletally mature patients aged 16 years or older with an isolated Weber B type fibula fracture and congruent ankle mortise in static ankle radiographs. INTERVENTIONS Participants were randomly allocated to conventional six week cast immobilisation (n=84) or three week treatment either in a cast (n=83) or in a simple orthosis (n=80). MAIN OUTCOME MEASURES The primary, non-inferiority, intention-to-treat outcome was the Olerud-Molander Ankle Score at 12 months (OMAS; range 0-100; higher scores indicate better outcomes and fewer symptoms). The predefined non-inferiority margin for the primary outcome was -8.8 points. Secondary outcomes were ankle function, pain, quality of life, ankle motion, and radiographic outcome. Follow-up assessments were performed at 6, 12, and 52 weeks. RESULTS 212 of 247 randomised participants (86%) completed the study. At 52 weeks, the mean OMAS was 87.6 (SD 18.3) in the six week cast group, 91.7 (SD 12.9) in the three week cast group, and 89.8 (SD 18.4) in the three week orthosis group. The between group difference at 52 weeks for the three week cast versus six week cast was 3.6 points (95% confidence interval -1.9 to 9.1, P=0.20), and for the three week orthosis versus six week cast was 1.7 points (-4.0 to 7.3, P=0.56). In both comparisons, the confidence intervals did not include the predefined inferiority margin of -8.8 points. The only statistically significant between group differences observed in the secondary outcomes and harms in the two primary comparisons were slight improvement in ankle plantar flexion and incidence of deep vein thrombosis, both in the three week orthosis group versus six week cast group. CONCLUSION Immobilisation for three weeks with a cast or orthosis was non-inferior to conventional cast immobilisation for six weeks in the treatment of an isolated stable Weber B type fracture.
Subject: OPERATIVE TREATMENT
FOLLOW-UP
STRESS RADIOGRAPHS
CLOSED TREATMENT
CAST
MOBILIZATION
BRACE
FOOT
3126 Surgery, anesthesiology, intensive care, radiology
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
bmj.k5432.full.pdf 750.1Kb PDF View/Open
bmj.l457.full.pdf 754.7Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record